| Name | protein kinase C (protein family or complex) |
|---|---|
| Synonyms | Protein kinase C; PKC |
| Name | fenvalerate |
|---|---|
| CAS | cyano(3-phenoxyphenyl)methyl 4-chloro-α-(1-methylethyl)benzeneacetate |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 11488435 | Kamei J, Sasaki M, Zushida K, Morita K, Tanaka S: Nociception and allodynia/hyperalgesia induced by intrathecal administration of fenvalerate. Jpn J Pharmacol. 2001 Jul;86(3):336-41. Calphostin C (3 pmol, i.t.), a protein kinase C inhibitor, inhibited fenvalerate-induced behavior. |
62(0,2,2,2) | Details |
| 12383951 | Kamei J, Iguchi E, Sasaki M, Zushida K, Morita K, Tanaka S: Modification of the fenvalerate-induced nociceptive response in mice by diabetes. Brain Res. 2002 Sep 6;948(1-2):17-23. Calphostin C (3 pmol, i.t.), a selective protein kinase C inhibitor, significantly inhibited intrathecal fenvalerate-induced nociceptive behavior with a rightward shift of the dose-response curve for fenvalerate-induced nociceptive behavior to the level those observed in non-diabetic mice. |
62(0,2,2,2) | Details |
| 9655866 | Huang RQ, Dillon GH: Maintenance of recombinant type A gamma-aminobutyric acid receptor function: role of protein phosphorylation and calcineurin. J Pharmacol Exp Ther. 1998 Jul;286(1):243-55. Inhibition of the Ca++/calmodulin-dependent phosphatase calcineurin with fenvalerate also prevented rundown of the response to |
0(0,0,0,0) | Details |